Presentation is loading. Please wait.

Presentation is loading. Please wait.

Clinical Pharmacokinetics Introduction. How to use this powerpoint presentation This supplements the other course material You can view it on line or.

Similar presentations


Presentation on theme: "Clinical Pharmacokinetics Introduction. How to use this powerpoint presentation This supplements the other course material You can view it on line or."— Presentation transcript:

1 Clinical Pharmacokinetics Introduction

2 How to use this powerpoint presentation This supplements the other course material You can view it on line or download it to your computer and view it without being connected to the internet. Work through the presentation at the start of the course and note any issue which are not clear. Read up on areas that you are not familiar with and revisit the presentation from time to time. Try the powerpoint based exercises

3 What is clinical pharmacokinetics ? Study of the time course of a drug’s movement through the body. Understanding of what the body does to (or with) the drug. Application of Therapeutic Drug Monitoring (TDM) and individualisation of drug therapy.

4 Outline Review of Concepts –Clearance, K, Half-Life, Volume of Distribution Therapeutic drug Monitoring Pharmacokinetic Drug Interactions Cases Discussion/Questions

5 Pharmacokinetics (PK) & pharmacodynamics (PD) PK - What the body does to the drug? –Absorption; distribution, metabolism, excretion (ADME) PD - What the drug does to the body? –Drug concentration at the site of action or in the plasma is related to a magnitude of effect

6 Plasma Site Concen- of tration Action Effects PKPD Pharmacokinetics (PK) and pharmacodynamics (PD) Dose

7 Pharmacokinetics vs Pharmacodynamics…concept Fluoxetine increases plasma concentrations of amitriptyline. This is a pharmacokinetic drug interaction. Fluoxetine inhibits the metabolism of amitriptyline and increases the plasma concentration of amitriptytline.

8 Pharmacokinetics vs Pharmacodynamics…concept If fluoxetine is given with tramadol serotonin syndrom can result. This is a pharmacodynamic drug interaction. Fluoxetine and tramadol both increase availability of serotonin leading to the possibility of “serotonin overload” This happens without a change in the concentration of either drug.

9 Basic Parameters In the next few slides the basic concepts and paramaters will be described and explained. In pharmacokinetics the body is represented as a single or multiple compartments in to which the drug is distributed. Some of the parameters are therefore a little abstract as we know the body is much more complicated !

10 V Volume 100 L Clearance 10 L/hr Volume of Distribution, Clearance and Elimination Rate Constant

11 V Volume 100 L (Vi) Clearance 10 L/hr Volume of Distribution, Clearance and Elimination Rate Constant V 2 Cardiac and Skeletal Muscle

12 V Volume 100 L (Vi) Clearance 10 L/hr V 2 Cardiac and Skeletal Muscle Volume of Distribution = Dose_______ Plasma Concentration

13 V Volume 100 L (Vi) Clearance 10 L/hr V 2 Cardiac and Skeletal Muscle Clearance = Volume of blood cleared of drug per unit time

14 V Volume 100 L (Vi) Clearance 10 L/hr V 2 Cardiac and Skeletal Muscle Clearance = 10 L/hr Volume of Distribution = 100 L What is the Elimination Rate Constant (k) ?

15 CL = kV k = 10 Lhr -1 = 0.1 hr L 10 % of the “Volume” is cleared (of drug) per hour k = Fraction of drug in the body removed per hour

16 CL = kV If V increases then k must decrease as CL is constant

17 Important Concepts VD is a theoretical Volume and determines the loading dose Clearance is a constant and determines the maintenance dose CL = kVD CL and VD are independent variables k is a dependent variable

18 Volume of Distribution Apparent volume of distribution is the theoretical volume that would have to be available for drug to disperse in if the concentration everywhere in the body were the same as that in the plasma or serum, the place where drug concentration sampling generally occurs.

19 Volume of Distribution An abstract concept Gives information on HOW the drug is distributed in the body Used to calculate a loading dose

20 Loading Dose Dose = Cp (Target) x VD

21 Question What Is the is the loading dose required fro drug A if; Target concentration is 10 mg/L VD is 0.75 L/kg Patients weight is 75 kg Answer is on the next slide

22 Answer: Loading Dose of Drug A Dose = Target Concentration x VD VD = 0.75 L/kg x 75 kg = L Target Conc. = 10 mg/L Dose = 10 mg/L x L = 565 mg This would probably be rounded to 560 or even 500 mg.

23 Clearance Ability of organs of elimination (e.g. kidney, liver to “clear” drug from the bloodstream Volume of fluid which is completely cleared of drug per unit time Units are in L/hr or L/hr/kg Pharmacokinetic term used in determination of maintenance doses

24 Maintenance Dose Calculation Maintenance Dose = CL x CpSS av CpSS av is the target average steady state drug concentration The units of CL are in L/hr or L/hr/kg Maintenance dose will be in mg/hr so for total daily dose will need multiplying by 24

25 Question What maintenance dose is required for drug A if; Target average SS concentration is 10 mg/L CL of drug A is L/kg/hr Patient weighs 75 kg Answer on next slide.

26 Answer Maintenance Dose = CL x CpSS av CL = L/hr/kg x 75 = L/hr Dose = L/hr x 10 mg/L = mg/hr So will need x 24 mg per day = 270 mg

27 Half-Life and k Half-life is the time taken for the drug concentration to fall to half its original value The elimination rate constant (k) is the fraction of drug in the body which is removed per unit time.

28 Drug Concentration Time C1C1 Exponential decay dC/dt  C = -k.C C2C2

29 Log Concn. Time C0C0 C 0 /2 t 1/2 Time to eliminate ~ 4 t 1/2

30 Integrating: Cp 2 = Cp 1.e -kt Logarithmic transform: lnC 2 = lnC 1 - kt logC 2 = logC 1 - kt/2.303 Elimination Half-Life: t 1/2 = ln2/k t 1/2 = 0.693/k

31 Steady-State Steady-state occurs after a drug has been given for approximately five elimination half-lives. At steady-state the rate of drug administration equals the rate of elimination and plasma concentration - time curves found after each dose should be approximately superimposable.

32 … … Accumulation to Steady State 100 mg given every half-life

33

34 What is Steady State (SS) ? Why is it important ? Rate in = Rate Out Reached in 4 – 5 half-lives (linear kinetics) Important when interpreting drug concentrations in TDM or assessing clinical response

35 Therapeutic Drug Monitoring Some Principles

36 Therapeutic Index Therapeutic index = toxic dose/effective dose This is a measure of a drug’s safety –A large number = a wide margin of safety –A small number = a small margin of safety

37 Drug Concentrations May Be Useful When There Is: l An established relationship between concentration and response or toxicity l A sensitive and specific assay l An assay that is relatively easy to perform l A narrow therapeutic range l A need to enhance response/prevent toxicity

38 Why Measure Drug Concentrations? Lack of therapeutic response Toxic effects evident Potential for non-compliance Variability in relationship of dose and concentration Therapeutic/toxic actions not easily quantified by clinical endpoints

39 Potential for Error When Using TDM Assuming patient is at steady-state Assuming patient is actually taking the drug as prescribed Assuming patient is receiving drug as prescribed Not knowing when the drug concentration was measured in relation to dose administration Assuming the patient is static and that changes in condition don’t affect clearance Not considering drug interactions


Download ppt "Clinical Pharmacokinetics Introduction. How to use this powerpoint presentation This supplements the other course material You can view it on line or."

Similar presentations


Ads by Google